{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:32:02Z","timestamp":1774467122087,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["15fk0210037h0101"],"award-info":[{"award-number":["15fk0210037h0101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Keio Gijuku Academic Development Funds"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179096","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T21:01:41Z","timestamp":1497560501000},"page":"e0179096","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8687-2760","authenticated-orcid":true,"given":"Po-sung","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhito","family":"Taniki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ojiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Amiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Makita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Ugamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Ikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Ebinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetsugu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"SI Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL Recommendations on Treatment of Hepatitis C 2015","volume":"63","year":"2015","journal-title":"Journal of hepatology"},{"key":"ref3","article-title":"APASL consensus statements and recommendation on treatment of hepatitis C","author":"M Omata","year":"2016","journal-title":"Hepatology international"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cgh.2009.11.018","article-title":"A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus","volume":"8","author":"AG Singal","year":"2010","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"RL Morgan","year":"2013","journal-title":"Annals of internal medicine"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease","volume":"149","author":"M Charlton","year":"2015","journal-title":"Gastroenterology"},{"issue":"1 Suppl","key":"ref7","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jhep.2016.07.039","article-title":"Reversion of disease manifestations after HCV eradication","volume":"65","author":"AJ van der Meer","year":"2016","journal-title":"Journal of hepatology"},{"key":"ref8","article-title":"Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution","author":"M Reig","year":"2016","journal-title":"Journal of hepatology"},{"key":"ref9","article-title":"Early Occurrence and Recurrence of Hepatocellular Carcinoma in HCV-related Cirrhosis Treated with Direct Acting Antivirals","author":"F Conti","year":"2016","journal-title":"Journal of hepatology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2016.06.023","article-title":"Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma","volume":"65","author":"JD Yang","year":"2016","journal-title":"Journal of hepatology"},{"key":"ref11","article-title":"Lack of evidence of an effect of Direct Acting Antivirals on the recurrence of hepatocellular carcinoma: The ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CIRVIR and CO23 CUPILT cohorts)","author":"S Pol","year":"2016","journal-title":"Journal of hepatology"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1172\/JCI75938","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome","volume":"124","author":"EG Meissner","year":"2014","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function","volume":"149","author":"E Serti","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiv391","article-title":"Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment","volume":"213","author":"M Spaan","year":"2016","journal-title":"The Journal of infectious diseases"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"e0125664","DOI":"10.1371\/journal.pone.0125664","article-title":"Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon\/Ribavirin Therapy in Chronic Hepatitis C","volume":"10","author":"PS Chu","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00535-014-1000-9","article-title":"MICA SNPs and the NKG2D system in virus-induced HCC","volume":"50","author":"K Goto","year":"2015","journal-title":"Journal of gastroenterology"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1172\/JCI69369","article-title":"Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis","volume":"123","author":"G Liu","year":"2013","journal-title":"The Journal of clinical investigation"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"E Mamessier","year":"2011","journal-title":"The Journal of clinical investigation"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/13547500902814658","article-title":"Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells","volume":"14","author":"G Konjevic","year":"2009","journal-title":"Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/QAI.0000000000000792","article-title":"Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ART","volume":"70","author":"E Giuliani","year":"2015","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1872-034X.2010.00674.x","article-title":"Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)","volume":"40","author":"M Kudo","year":"2010","journal-title":"Hepatology research: the official journal of the Japan Society of Hepatology"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hepr.12542","article-title":"Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)","volume":"46","author":"M Kudo","year":"2016","journal-title":"Hepatology research: the official journal of the Japan Society of Hepatology"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/hep.20717","article-title":"Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C","volume":"41","author":"C Lackner","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"A Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"X Forns","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-131-3-199908030-00003","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy","volume":"131","author":"H Yoshida","year":"1999","journal-title":"Annals of internal medicine"},{"key":"ref27","article-title":"Risk of Hepatocellular Carcinoma after Sustained Virologic Response in Veterans with HCV-infection","author":"HB El-Serag","year":"2016","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"LG Guidotti","year":"2006","journal-title":"Annual review of pathology"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2893.2006.00733.x","article-title":"Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis","volume":"13","author":"M Clemente","year":"2006","journal-title":"Journal of viral hepatitis"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"W Liu","year":"2006","journal-title":"The Journal of experimental medicine"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hep.26442","article-title":"alpha-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C","volume":"58","author":"Y Asahina","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ajcp\/111.6.811","article-title":"Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores","volume":"111","author":"NS Goldstein","year":"1999","journal-title":"American journal of clinical pathology"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","article-title":"Hepatocellular carcinoma: clinical frontiers and perspectives","volume":"63","author":"J Bruix","year":"2014","journal-title":"Gut"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2015.06.021","article-title":"Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy","volume":"63","author":"JJ Subleski","year":"2015","journal-title":"Journal of hepatology"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.2004.02586.x","article-title":"Hepatic interleuklin 15 (IL-15) expression: implications for local NK\/NKT cell homeostasis and development","volume":"138","author":"L Golden-Mason","year":"2004","journal-title":"Clinical and experimental immunology"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.4049\/jimmunol.171.10.5423","article-title":"Autocrine\/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection","volume":"171","author":"M Jinushi","year":"2003","journal-title":"Journal of immunology"},{"key":"ref37","article-title":"Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy with Direct-Acting Antivirals","author":"S Prenner","year":"2017","journal-title":"Journal of hepatology"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00795-008-0434-7","article-title":"Natural killer cell receptors and their ligands in liver diseases","volume":"42","author":"S Yamagiwa","year":"2009","journal-title":"Medical molecular morphology"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2009.05.030","article-title":"Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C","volume":"51","author":"P Bonorino","year":"2009","journal-title":"Journal of hepatology"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.21073","article-title":"Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing","volume":"43","author":"C Morishima","year":"2006","journal-title":"Hepatology"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/infdis\/jis210","article-title":"Interferon alpha-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1","volume":"205","author":"KA Stegmann","year":"2012","journal-title":"The Journal of infectious diseases"},{"issue":"6908","key":"ref42","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"V Groh","year":"2002","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"DH Raulet","year":"2013","journal-title":"Annual review of immunology"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"e1001184","DOI":"10.1371\/journal.ppat.1001184","article-title":"Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines","volume":"6","author":"D Sene","year":"2010","journal-title":"PLoS pathogens"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-065X.2006.00445.x","article-title":"The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression","volume":"214","author":"F Ghiringhelli","year":"2006","journal-title":"Immunological reviews"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner","volume":"202","author":"F Ghiringhelli","year":"2005","journal-title":"The Journal of experimental medicine"},{"key":"ref47","article-title":"Increased peripheral cd4+ regulatory t cells persist after successful direct-acting antiviral treatment of chronic hepatitis C","author":"B Langhans","year":"2016","journal-title":"Journal of hepatology"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/civ474","article-title":"Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir. Clinical infectious diseases: an official publication of the","volume":"61","author":"JM Collins","year":"2015","journal-title":"Infectious Diseases Society of America"},{"key":"ref49","article-title":"Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents","author":"MC Perello","year":"2016","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10147-010-0150-x","article-title":"Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma","volume":"16","author":"H Hagihara","year":"2011","journal-title":"International journal of clinical oncology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T17:22:33Z","timestamp":1750353753000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179096"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179096","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}